Molecular classification of breast phyllodes tumors: Validation of the histologic grading scheme and insights into malignant progression

Breast Cancer Research and Treatment

Volumn 129, Issue 2, 2011, Pages 319-329

  Ang, Mei Kim ^a   Ooi, Aik Seng ^a,b   Thike, Aye Aye ^c   Tan, Patrick ^a   Zhang, Zhongfa ^d   Dykema, Karl ^b   Furge, Kyle ^b   Teh, Bin Tean ^a,b   Tan, Puay Hoon ^c  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b VAN ANDEL RESEARCH INSTITUTE   (United States)

^c SINGAPORE GENERAL HOSPITAL   (Singapore)

^d WISTAR INSTITUTE   (United States)

Author keywords

Comparative genomic microarray analysis; Gene expression; Histological grade; Malignant progression; Phyllodes tumors

Indexed keywords

HOX PROTEIN; HOXB13 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASIAN; BENIGN TUMOR; BREAST CARCINOGENESIS; CANCER CLASSIFICATION; CANCER GRADING; CELL ADHESION; CELL PROLIFERATION; CHROMOSOME 1Q; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTOSARCOMA PHYLLOIDES; EPIDERMIS; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT TRANSFORMATION; MASTECTOMY; MICROARRAY ANALYSIS; MOLECULAR GENETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; VALIDATION PROCESS; WIDE EXCISION;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CHI-SQUARE DISTRIBUTION; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM GRADING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHYLLODES TUMOR; PROGNOSIS; SINGAPORE; SURVIVAL RATE; TIME FACTORS;

EID: 80052645745     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1204-5     Document Type: Article

References (46)

1. Rosen PP, Dershaw D, Liberman L (1999) Breast pathology. Lippincott, Williams and Wilkins, Philadelphia
2. M Reinfuss J Mitus K Duda, et al. 1996 The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases Cancer 77 910 916 8608483 10.1002/(SICI)1097-0142(19960301)77:5<910::AID-CNCR16>3.0. CO;2-6 1:STN:280:DyaK287osFeksg%3D%3D (Pubitemid 26061285)
3. M Pietruszka L Banes 1978 Cystosarcoma phyllodes: a clinicopathological analysis of 42 cases Cancer 41 1974 1983 206344 10.1002/1097-0142(197805)41: 5<1974::AID-CNCR2820410543>3.0.CO;2-C 1:STN:280:DyaE1c7mslWjtw%3D%3D (Pubitemid 8348551)
4. JD Halverson JM Hori-Rubaina 1974 Cystosarcoma phyllodes of the breast Am Surg 40 295 301 4362487 1:STN:280:DyaE2c7ktVWitw%3D%3D
5. PH Tan T Jayabaskar K-L Chuah H-Y Lee Y Tan M Hilmy H Hung S Selvarajan B-H Bay 2005 Phyllodes tumors of the breast-the role of pathologic parameters Am J Clin Pathol 123 529 540 15743740 10.1309/U6DVBFM81MLJC1FN (Pubitemid 40418548)
6. Jones AM, Mitter R, Springall R, Graham T, Winter E, Gillat C, Hanby AM, The Phyllodes Tumour Consortium, Tomlinson IPM, Sawyer EJ (2008) A comprehensive genetic profile of phyllodes tumors of the breast detects important mutations, intra-tumoral genetic heterogeneity and new genetic changes on recurrence. J Pathol 214:533-544 (Pubitemid 351482269)
7. ZK Rooshdiya RA Scolyer GM Tse PH Tan TC Putti CS Lee 2009 Pathogenic mechanisms in the initiation and progression of mammary phyllodes tumours Pathology 41 105 117 10.1080/00313020802579342
8. K Yonemori T Hasegawa C Shimizu, et al. 2006 Correlation of p53 and MIB-1 expression with both the systemic recurrence and survival in cases of phyllodes tumors of the breast Pathol Res Pract 202 10 705 712 16889904 10.1016/j.prp.2006.05.006 1:CAS:528:DC%2BD28Xht12rurvI (Pubitemid 44356425)
9. GM Tse TC Putti FY Kung, et al. 2002 Increased p53 protein expression in malignant mammary phyllodes tumors Mod Pathol 15 7 734 740 12118111 10.1097/01.MP.0000018978.75312.5C (Pubitemid 34787309)
10. Z Gatalica S Finkelstein E Lucio, et al. 2001 p53 protein expression and gene mutation in phyllodes tumors of the breast Pathol Res Pract 197 3 183 187 11314782 10.1078/0344-0338-00031 1:CAS:528:DC%2BD3MXjvVaktrc%3D (Pubitemid 32273376)
11. EJ Sawyer R Poulsom FT Hunt, et al. 2003 Malignant phyllodes tumors show stromal overexpression of c-myc and c-kit J Pathol 200 1 59 64 12692842 10.1002/path.1318 1:CAS:528:DC%2BD3sXkt1aktbg%3D (Pubitemid 36592637)
12. PH Tan T Jayabaskar G Yip Y Tan M Hilmy S Selvarajan BH Bay 2005 p53 and c-kit (CD117) protein expression as prognostic indicators in breast phyllodes tumors: a tissue microarray study Mod Pathol 18 1527 1530 16258510 10.1038/modpathol.3800254 1:CAS:528:DC%2BD2MXht1aqsr7N (Pubitemid 40395356)
13. S Carvalho AO e Silva F Milanezi S Ricardo D Leitao I Amendoeira FC Schmitt 2004 c-KIT and PDGFRA in breast phyllodes tumours: overexpression without mutations? J Clin Pathol 57 1075 1079 15452163 10.1136/jcp.2004.016378 1:CAS:528:DC%2BD2cXps1Kls7c%3D (Pubitemid 39331359)
14. C Kersting A Kuijper H Schmidt, et al. 2006 Amplifications of the epidermal growth factor receptor gene (EGFR) are common in phyllodes tumors of the breast and are associated with tumor progression Lab Invest 86 1 54 61 16258523 10.1038/labinvest.3700358 1:CAS:528:DC%2BD2MXhtlWjsr%2FI (Pubitemid 43250968)
15. GM Tse PC Lui JS Vong KM Lau TC Putti R Karim RA Scolyer CS Lee AM Yu DC Ng AK Tse PH Tan 2009 Increased epidermal growth factor receptor (EGFR) expression in malignant mammary phyllodes tumors Breast Cancer Res Treat 114 441 448 18443904 10.1007/s10549-008-0030-5 1:CAS:528:DC%2BD1MXisFSqtL8%3D
16. A Kuijper P van der Groep E van der Wall PJ van Diest 2005 Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast Breast Cancer Res 7 R808 R818 16168127 10.1186/bcr1296 1:CAS:528:DC%2BD2MXpvFOgtbk%3D
17. GM Tse AK Tsang TC Putti RA Scolyer PC Lui BK Law RZ Karim CS Lee 2005 Stromal CD10 expression in mammary fibroadenomas and phyllodes tumours J Clin Pathol 58 185 189 15677540 10.1136/jcp.2004.020917 1:STN:280: DC%2BD2M%2FltVWisQ%3D%3D (Pubitemid 40193805)
18. GM Tse FC Wong AK Tsang CS Lee PC Lui AW Lo BK Law RA Scolyer RZ Karim TC Putti 2005 Stromal nitric oxide synthase (NOS) expression correlates with the grade of mammary phyllodes tumour J Clin Pathol 58 600 604 15917410 10.1136/jcp.2004.023028 1:CAS:528:DC%2BD2MXlvFChsb0%3D (Pubitemid 40814019)
19. CY Koo BH Bay PC Lui, et al. 2006 Immunohistochemical expression of heparan sulfate correlates with stromal cell proliferation in breast phyllodes tumors Mod Pathol 19 10 1344 1350 16862076 10.1038/modpathol.3800657 1:CAS:528:DC%2BD28Xps1yjsr8%3D (Pubitemid 44423082)
20. A Niezabitowski B Lackowska J Rys, et al. 1001 Prognostic evaluation of proliferative activity and DNA content in the phyllodes tumor of the breast: immunohistochemical and flow cytometric study of 118 cases Breast Cancer Res Treat 65 1 77 85 10.1023/A:1006457304526
21. GM Tse PC Lui CS Lee FY Kung RA Scolyer BK Law TS Lau R Karim TC Putti 2004 Stromal expression of vascular endothelial growth factor correlates with tumor grade and microvessel density in mammary phyllodes tumors: a multicenter study of 185 cases Hum Pathol 35 1053 1057 15343505 10.1016/j.humpath.2004.01. 023 1:CAS:528:DC%2BD2cXntFCjsLk%3D (Pubitemid 39165335)
22. GM Tse TK Ma KF Chan BK Law MH Chen KH Li EC Chan MK Mak 2001 Increased microvessel density in malignant and borderline mammary phyllodes tumours Histopathology 38 567 570 11422501 10.1046/j.1365-2559.2001.01150.x 1:STN:280:DC%2BD3MzovFKksw%3D%3D (Pubitemid 32863010)
23. A Kuijper RA de Vos JH Lagendijk E van der Wall PJ van Diest 2005 Progressive deregulation of the cell cycle with higher tumor grade in the stroma of breast phyllodes tumors Am J Clin Pathol 123 690 698 15981808 10.1309/BLDY9KWNVMUQ202U (Pubitemid 40586486)
24. EJ Sawyer AM Hanby AJ Rowan CE Gillett RE Thomas R Poulsom SR Lakhani IO Ellis P Ellis IP Tomlinson 2002 The Wnt pathway, epithelial-stromal interactions, and malignant progression in phyllodes tumours J Pathol 196 437 444 11920740 10.1002/path.1067 1:CAS:528:DC%2BD38XjtVCgsLY%3D (Pubitemid 34262856)
25. EJ Sawyer AM Hanby R Poulsom R Jeffery CE Gillett IO Ellis P Ellis IP Tomlinson 2003 Beta-catenin abnormalities and associated insulin-like growth factor expression are important in phyllodes tumours and fibroadenomas of the breast J Pathol 200 627 632 12898599 10.1002/path.1391 1:CAS:528: DC%2BD3sXntl2nurY%3D (Pubitemid 36987312)
26. M Lae A Vincent-Salomon A Savignoni I Huon P Freneaux B Sigal-Zafrani A Aurias X Sastre-Garau J Couturier 2007 Phyllodes tumors of the breast segregate in two groups according to genetic criteria Mod Pathol 20 435 444 17334353 10.1038/modpathol.3800756 1:CAS:528:DC%2BD2sXjtlyltro%3D (Pubitemid 46482367)
27. S Lv Y Niu L Wei Q Liu X Wang Y Chen 2008 Chromosomal aberrations and genetic relations in benign, borderline and malignant phyllodes tumors of the breast: a comparative genomic hybridization study Breast Cancer Res Treat 112 411 418 18189161 10.1007/s10549-007-9876-1
28. K Agelopoulos C Kersting E Korsching H Schimdt A Kuijper C August P Wulfing J Tio W Boecker PJ van Diest B Brandt H Buerger 2007 EGFR amplification specific gene expression in phyllodes tumours of the breast Cell Oncol 29 443 451 18032821 1:CAS:528:DC%2BD2sXhtlajtL%2FO (Pubitemid 350136499)
29. Jones AM, Mitter R, Poulsom R, Gillett C, Hanby AM, Pyhllodes Tumour Consortium, Tomlinson IPM, Sawyer EJ (2008) mRNA expression profiling of phyllodes tumours of the breast: identification of genes important in the development of borderline and malignant phyllodes tumours. J Pathol 216:408-417
30. XJ Yang MH Tan HL Kim, et al. 2005 A molecular classification of papillary renal cell carcinoma Cancer Res 65 5628 5637 15994935 10.1158/0008-5472.CAN-05-0533 1:CAS:528:DC%2BD2MXlslOqs7k%3D (Pubitemid 40911163)
31. R Ihaka R Gentleman 1996 R: a language for data analysis and graphics J Comput Graph Stat 5 299 314 10.2307/1390807
32. RC Gentleman VJ Carey DM Bates B Bolstad M Dettling S Dudoit B Ellis L Gautier Y Ge J Gentry K Hornik T Hothorn W Huber S Iacus R Irizarry F Leisch C Li M Maechler AJ Rossini G Sawitzki C Smith G Smyth L Tierney J Yang J Zhang 2004 Bioconductor: open software development for computational biology and bioinformatics Genome Biol 5 R80 15461798 10.1186/gb-2004-5-10-r80
33. M Dai P Wang AD Boyd G Kostov B Athey EG Jones WE Bunney RM Myers TP Speed H Akil SJ Watson F Meng 2005 Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data Nucl Acids Res 33 e175 16284200 10.1093/nar/gni179 (Pubitemid 41806403)
34. KJ Dykema KA Furge 2004 Diminished transcription of chromosome arm 4q is inversely related to local spreading of hepatocellular carcinoma Genes Chromosom Cancer 41 4 390 394 15390189 10.1002/gcc.20090 1:CAS:528:DC%2BD2cXhtVOqtrzE (Pubitemid 39488497)
35. Smyth GK (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Statistical applications in genetics and molecular biology [electronic resource 3004:3:Article 3
36. Y Benjamini Y Hochberg 1995 Controlling the false discovery rate: a practical and powerful approach to multiple testing J R Stat Soc B 57 289 300
37. L Zeltser C Desplan N Heintz 1996 Hoxb-13: a new Hox gene in a distant region of the HOXB cluster maintains colinearity Development 122 2475 2484 8756292 1:CAS:528:DyaK28XltFWntLw%3D (Pubitemid 26265606)
38. X-J Ma Z Wang PD Ryan SJ Isakoff A Barmettler A Fuller B Muir G Mohapatra R Salunga JT Tuggle Y Tran D Tran A Tassin P Amon W Wang W Wang E Enright K Stecker E Estepa-Sabal B Smith J Younger U Balis J Michaelson A Bhan K Habin TM Baer J Brugge DA Haber MG Erlander DC Sgroi 2004 A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen Cancer Cell 5 607 616 15193263 10.1016/j.ccr.2004.05.015 1:CAS:528: DC%2BD2cXltlGgsLs%3D (Pubitemid 38748922)
39. M Cantile G Pettinato A Procino I Feliciello L Cindolo C Cillo 2003 In vivo expression of the whole HOX gene network in human breast cancer Eur J Cancer 39 257 264 12509959 10.1016/S0959-8049(02)00599-3 1:CAS:528: DC%2BD38XpvVWntL8%3D (Pubitemid 36057077)
40. T Yamashita S Tazawa Z Yawei H Katayama Y Kato K Nishiwaki Y Yokohama M Ishikawa 2006 Suppression of invasive characteristics by antisense introduction of overexpression HOX genes in ovarian cancer cells Int J Oncol 28 931 938 16525643 1:CAS:528:DC%2BD28XjtlCqtLk%3D
41. J Miao Z Wang H Porvencher B Muir S Dahiya E Carney C-O Leong D Sgroi S Orsulic 2007 HOXB13 promotes ovarian cancer progression PNAS 104 43 17093 17098 17942676 10.1073/pnas.0707938104 1:CAS:528:DC%2BD2sXht1KgtLfE (Pubitemid 350210997)
42. C Jung R-S Kim H Zhang S-J Lee H Sheng PJ Loehrer TA Gardner M-H Jeng C Kao 2005 HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation Br J Cancer 92 2233 2239 15928669 10.1038/sj.bjc.6602631 1:CAS:528:DC%2BD2MXltVygtLg%3D (Pubitemid 40966262)
43. C Jung RS Kim H Zhang SJ Lee MH Jeng 2004 HOXB13 induces growth suppression of prostate cancer cells as a repressor of hormone-activated androgen receptor signalling Cancer Res 64 9185 9192 15604291 10.1158/0008-5472.CAN-04-1330 1:CAS:528:DC%2BD2cXhtVOmsb%2FL (Pubitemid 39665535)
44. C Jung RS Kim SJ Lee C Wang MH Jeng 2004 HOXB13 homeodomain protein suppresses the growth of prostate cancer cells by the negative regulation of T-cell factor 4 Cancer Res 64 3046 3051 15126340 10.1158/0008-5472.CAN-03-2614 1:CAS:528:DC%2BD2cXjs1ehsbY%3D (Pubitemid 38581403)
45. C Abate-Shen 2002 Dergulated homeobox gene expression in cancer: cause or consequence? Nat Rev Cancer 2 777 785 12360280 10.1038/nrc907 1:CAS:528:DC%2BD38XnsVGrtbs%3D (Pubitemid 37328912)
46. Tse GMK, Niu Y, Shi H-J (2009) Phyllodes tumor of the breast: an update. Breast Cancer (2009 May 12, Epub)